<DOC>
	<DOCNO>NCT00181883</DOCNO>
	<brief_summary>This 8-week open-label study aim assess effectiveness tolerability Quetiapine , treatment preschool child age 4 6 year bipolar bipolar spectrum disorder . This exploratory , pilot study , seek determine whether Quetiapine efficacious well tolerate treatment preschooler pediatric bipolar bipolar spectrum disorder age group . The study result use generate hypothesis large randomize control clinical trial explicit hypotheses sufficient statistical power .</brief_summary>
	<brief_title>Quetiapine Mania In Preschool Children 4 6 Years Age With Bipolar Disorder</brief_title>
	<detailed_description>Seroquel psychotropic agent affect multiple neurotransmitter receptor brain : serotonin 5HT1A 5HT2 , dopamine D1 D2 , histamine H1 ( IC50=30nM ) , adrenergic receptor . This 8-week open-label study aim assess effectiveness tolerability Quetiapine , treatment preschool child age 4 6 year bipolar bipolar spectrum disorder . This exploratory , pilot study , seek determine whether Quetiapine efficacious well tolerate treatment preschooler pediatric bipolar bipolar spectrum disorder age group . The study result use generate hypothesis large randomize control clinical trial explicit hypotheses sufficient statistical power .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Male female subject , 46 year age . Subjects must DSMIV diagnosis bipolar I , bipolar II disorder bipolar spectrum disorder currently display manic , hypomanic , mixed symptom ( without psychotic feature ) accord DSMIV base clinical assessment confirm structured diagnostic interview ( Kidd Schedule Affective Disorders Schizophrenia Epidemiological Version ) . Bipolar spectrum disorder ( subthreshold bipolar disorder ) operationalized severe mood disturbance , meet DSMIV Criteria A bipolar disorder meet few element criterion B ( require 2 item elation category 3 irritability ) . Subjects legal representative must level understanding sufficient communicate intelligently investigator study coordinator , cooperate test examination require protocol . Subjects legal representative must consider reliable . Each subject his/her authorized legal representative must understand nature study . The subject 's authorized legal representative must sign informed consent document . Subjects must initial score Young Mania Rating Scale ( YMRS ) total score least 20 . Subject must able participate mandatory blood draw . Subjects comorbid Attention Deficit Hyperactivity Disorder ( ADHD ) , Oppositional Defiant Disorder ( ODD ) , Conduct Disorder ( CD ) , anxiety depressive disorder allow participate study provide meet exclusionary criterion . For concomitant stimulant therapy use treat ADHD , subject must stable dose medication 1 month prior study enrollment . The dose stimulant therapy change throughout duration study . Investigator his/her immediate family ; define investigator 's spouse , parent , child , grandparent , grandchild . Serious , unstable illness include hepatic , renal , gastroenterological , respiratory , cardiovascular ( include ischemic heart disease ) , endocrinologic , neurologic , immunologic , hematologic disease . Uncorrected hypothyroidism hyperthyroidism . History severe allergy multiple adverse drug reaction . Nonfebrile seizures without clear resolve etiology . Leukopenia history leukopenia without clear resolve etiology . Judged clinically serious suicidal risk . Any concomitant medication primarily central nervous system activity specify Concomitant Medication portion protocol . A nonresponder history intolerance adequate trial Quetiapine ( 2 month adequate dose ) determine clinician . Current diagnosis schizophrenia . Non English speaking subject allow study follow reason : ) assessment instrument available adequately standardized language ; b ) clinical trial facility locate Cambridge MGH main campus without availability translator ; c ) psychiatric questionnaire evaluation tax add complexity translator potential make patient experience even exhaust .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>child</keyword>
	<keyword>bipolar disorder</keyword>
	<keyword>quetiapine</keyword>
	<keyword>preschooler</keyword>
</DOC>